If you check out the corporate presentation (home page of their website, under recent news) they really give a detailed description of their pipeline. Not an MD, but the lead compound RE-021 looks pretty good. 6 week study enrolling 1H13. Also not a mathematician, but it looks to me like orphan drug economics + near term catalyst = ????